Literature DB >> 29509059

MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.

Xiaofeng Xu1, Feng Gao2, Jianjiang Wang2, Lan Tao3, Jinsong Ye1, Li Ding1, Wei Ji1, Xing Chen4.   

Abstract

OBJECTIVE: To explore the relationship between miR-122-5p and DUSP4 and their effects on gastric cancer (GC) cell mobility and invasiveness.
METHODS: Abnormally expressed miRNAs and mRNAs were analyzed using microarrays. The miR-122-5p and DUSP4 mRNA expression levels in GC tissues and cells were determined by RT-qPCR. The target relationship between miR-122-5p and DUSP4 was validated by dual luciferase reporter assay. GC cell mobility and invasiveness were respectively observed by wound healing assay and transwell invasion assay. Western blot and immunohistochemistry were used for detection of the expressions of DUSP4 protein and MMP2 and MMP9 proteins related to cell invasion and migration. The migration and invasion abilities of gastric cancer cells in vivo were evaluated according to the number of lung metastatic nodules in mice.
RESULTS: The expression of miR-122-5p in GC tissues and cells was significantly down-regulated, whereas DUSP4 expression was up-regulated. Bioinformatics prediction strategies and dual luciferase reporter assay verified the binding sites of miR-122-5p on 3'UTR of DUSP4 and the target relationship between miR-122-5p and DUSP4. Overexpression of miR-122-5p and knockdown of DUSP4 in BGC-823 cells observantly suppressed GC cell mobility and invasiveness, whereas downregulation of miR-122-5p expression promoted cell metastasis. MiR-122-5p inhibited GC cell mobility and invasiveness and pulmonary tumor metastasis via downregulation of DUSP4.
CONCLUSION: MiR-122-5p restrained migration and invasion abilities of GC cells by repressing DUSP4.

Entities:  

Keywords:  DUSP4; Gastric cancer; invasion; miR-122-5p; migration

Mesh:

Substances:

Year:  2018        PMID: 29509059      PMCID: PMC5915035          DOI: 10.1080/15384047.2018.1423925

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  36 in total

1.  Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.

Authors:  Qingjuan Chen; Xiaojun Ge; Yuchen Zhang; Hongwei Xia; Dandan Yuan; Qiulin Tang; Liang Chen; Xiaohui Pang; Weibing Leng; Feng Bi
Journal:  Oncol Rep       Date:  2014-01-28       Impact factor: 3.906

2.  MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells.

Authors:  Hengchun Zhang; Zhiguo Sun; Yan Li; Dong Fan; Hao Jiang
Journal:  Biomed Pharmacother       Date:  2017-01-20       Impact factor: 6.529

3.  miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.

Authors:  Edit Miko; Zoltán Margitai; Zsolt Czimmerer; Ildikó Várkonyi; Balázs Dezso; Arpád Lányi; Zsolt Bacsó; Beáta Scholtz
Journal:  FEBS Lett       Date:  2011-03-23       Impact factor: 4.124

4.  Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.

Authors:  Justin M Balko; Luis J Schwarz; Neil E Bhola; Richard Kurupi; Phillip Owens; Todd W Miller; Henry Gómez; Rebecca S Cook; Carlos L Arteaga
Journal:  Cancer Res       Date:  2013-08-21       Impact factor: 12.701

5.  Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction.

Authors:  Xin-Liang Yao; Xue-Li Lu; Cheng-Yun Yan; Qi-Lin Wan; Guan-Chang Cheng; Yan-Ming Li
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

6.  DUSPs, to MAP kinases and beyond.

Authors:  Ching-Yu Huang; Tse-Hua Tan
Journal:  Cell Biosci       Date:  2012-07-09       Impact factor: 7.133

7.  MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.

Authors:  Xufu Wei; Chengyong Tang; Xiuxian Lu; Rui Liu; Mi Zhou; Diao He; Daofeng Zheng; Chao Sun; Zhongjun Wu
Journal:  Oncotarget       Date:  2015-07-30

Review 8.  Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Wei Huang; Hsiang-Cheng Chi; Yang-Hsiang Lin; Pei-Hsuan Lu; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2016-06-16       Impact factor: 5.923

9.  The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.

Authors:  Xiaolu Zhang; Jiping Zeng; Minran Zhou; Bingnan Li; Yuanyuan Zhang; Tao Huang; Lixiang Wang; Jihui Jia; Chunyan Chen
Journal:  Mol Cancer       Date:  2012-08-17       Impact factor: 27.401

10.  miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression.

Authors:  Liduan Zheng; Wanju Jiao; Huajie Song; Hongxia Qu; Dan Li; Hong Mei; Yajun Chen; Feng Yang; Huanhuan Li; Kai Huang; Qiangsong Tong
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

View more
  29 in total

1.  [miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].

Authors:  Jingrong Li; Rui Zhao; Ruihua Fang; Jianqin Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

2.  MiR-122-5p suppresses neuropathic pain development by targeting PDK4.

Authors:  Lanlan Wan; Zhen Su; Fayin Li; Pengfei Gao; Xianlong Zhang
Journal:  Neurochem Res       Date:  2021-02-10       Impact factor: 3.996

3.  Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway.

Authors:  Lei Kong; Qinghua Wu; Liangchao Zhao; Jinhua Ye; Nengping Li; Huali Yang
Journal:  Cell Cycle       Date:  2019-05-20       Impact factor: 4.534

4.  Identification of key miRNA-gene pairs in gastric cancer through integrated analysis of mRNA and miRNA microarray.

Authors:  Tieming Zhu; Qiuyue Lou; Zhewei Shi; Ganghong Chen
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

5.  Circ_MTM1 knockdown inhibits the progression of HBV-related liver fibrosis via regulating IL7R expression through targeting miR-122-5p.

Authors:  Bin Li; Yonggang Li; Shuhua Li; Hongwei Li; Ling Liu; Haiying Yu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

6.  Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer.

Authors:  Seung Sam Paik; Seongsik Bang; Seungyun Jee; Hyunsung Kim; Kiseok Jang; Hosub Park; Jae Kyung Myung; Dongho Choi; Su-Jin Shin
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

7.  Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis.

Authors:  Zhihui Gao; Qianqing Wang; Mei Ji; Xiangcui Guo; Li Li; Xiaoke Su
Journal:  J Transl Med       Date:  2021-05-30       Impact factor: 5.531

8.  miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.

Authors:  Ning Hu; Yanhua Tian; Yanmei Song; Leilei Zang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

9.  Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA.

Authors:  Kang Cui; Shuiling Jin; Yabing Du; Junlin Yu; Han Feng; Qingxia Fan; Wang Ma
Journal:  Cancer Cell Int       Date:  2019-07-30       Impact factor: 5.722

10.  miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer.

Authors:  Suguru Maruyama; Shinji Furuya; Kensuke Shiraishi; Hiroki Shimizu; Hidenori Akaike; Naohiro Hosomura; Yoshihiko Kawaguchi; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.